Atlas Trials

Non-Small Cell Lung Cancer Stage IIIA

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-Small Cell Lung Cancer Stage IIIA

RecordFirmDate
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy (NCT04716946)Memorial Sloan Kettering Cancer Center2021-01-27
Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC (NCT04455594)The First Affiliated Hospital of Guangzhou Medical University2020-10-01
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC (NCT04699721)Xiangya Hospital of Central South University2020-07-01
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer (NCT03628144)H. Lee Moffitt Cancer Center and Research Institute2020-07-01
Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) (NCT04040361)Masahiro Tsuboi2019-11-30
Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer (NCT03396185)Betta Pharmaceuticals Co., Ltd.2018-05-09
To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer (NCT02977169)Shanghai Chest Hospital2016-11-01
Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection (NCT02223611)Hebei Medical University Fourth Hospital2014-12-01
Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC) (NCT01991418)Hunan Province Tumor Hospital2013-05-01
Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection (NCT01926483)Zhejiang Cancer Hospital2013-03-01
Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations (NCT01410214)Chinese Lung Cancer Surgical Group2011-05-01

Track Non-Small Cell Lung Cancer Stage IIIA automatically

Every clearance here is in the API, with alerts when new ones post.